AI brain scans could revolutionize MS care

NCT ID NCT07032246

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: icometrix Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether using an AI tool to analyze brain MRIs helps doctors spot signs of multiple sclerosis (MS) activity more accurately. About 750 people with MS or early warning signs will be split into two groups: one where doctors use the AI tool, and one where they rely on standard MRI reports. The goal is to see if AI leads to better treatment decisions and fewer MS flare-ups over two years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLINICALLY ISOLATED SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis Nerve Degeneration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CLINICALLY ISOLATED SYNDROME MULTIPLE SCLEROSIS RADIOLOGICALLY ISOLATED SYNDROME

Contacts and locations

Locations

ASST Papa Giovanni XXIII Bergamo

Bergamo, Italy
Casa di Cura Igea

Milan, Italy
Charité - Universitätsmedizin Berlin

Berlin, State of Berlin, 131256, Germany
General University Hospital Prague

Prague, Prague, 2 128 00, Czechia
Katholisches Klinikum Bochum - St. Joseph-Hospital

Bochum, North Rhine-Westphalia, 44791, Germany
Technische Universität Dresden

Dresden, Saxony, 01062, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.